DXTX-1464

N/A

Report date: 2026/01/07 10:16:08
NMEFirst In Class

Base Information

Drug NameDXTX-1464
Drug Alias NameDXTX-1464
ClassificationSmall molecules
Mechanisms of ActionCyclin-dependent kinase 2 degradersG1/S-specific cyclin-E1 degradersG1/S-specific cyclin-E2 degraders
TargetsCyclin-dependent kinase 2G1/S-specific cyclin-E1G1/S-specific cyclin-E2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDifferentiated Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesDifferentiated Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A